Arrowstreet Capital’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Arrowstreet Capital’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,700	Closed	-$1.24M	–	2427
2021 Q1	$1.24M	Buy	+5,700	New	+$1.07M	﹤0.01%	1721
2019 Q4	–	Sell	-25,530	Closed	-$2.94M	–	1982
2019 Q3	$2.94M	Buy	+25,530	New	+$3.87M	0.01%	863
2019 Q2	–	Sell	-31,195	Closed	-$5.26M	–	1848
2019 Q1	$5.26M	Buy	31,195 +11,895	+62%	+$1.77M	0.01%	778
2018 Q4	$1.88M	Buy	+19,300	New	+$2.53M	﹤0.01%	804
2018 Q3	–	Sell	-15,000	Closed	-$2.09M	–	1330
2018 Q2	$2.09M	Buy	+15,000	New	+$2.13M	0.01%	681

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Arrowstreet Capital's GWPH Position: Q2 2021 in Review

Arrowstreet Capital sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 5,700 shares — an estimated $1.24M sold.

Arrowstreet Capital first reported a position in GWPH in Q2 2018 and held it in 5 quarters. The position peaked at $5.26M in Q1 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Arrowstreet Capital reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Arrowstreet Capital sold 5,700 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $1.24M.
Arrowstreet Capital first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 5 quarters.
Arrowstreet Capital's GW Pharmaceuticals Plc American Depositary Shares position peaked at $5.26M in Q1 2019.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Arrowstreet Capital's 13F filing for Q2 2021, filed 13 Aug 2021.